Single-Domain Amnestic Mild Cognitive Impairment Identified by Cluster Analysis Predicts Alzheimer’s Disease in the European Prospective DESCRIPA Study by Damian, Marinella et al.
 © 2013 S. Karger AG, Basel
1420–8008/13/0362–0001$38.00/0 
 Original Research Article 
 Dement Geriatr Cogn Disord 2013;36:1–19 
 Single-Domain Amnestic Mild Cognitive 
Impairment Identified by Cluster Analysis 
Predicts Alzheimer’s Disease in the European 
Prospective DESCRIPA Study 
 Marinella Damian a    Lucrezia Hausner a    Katrin Jekel a, b    Melany Richter a    
Lutz Froelich a    Ove Almkvist e    Merce Boada i    Roger Bullock j    
Peter Paul De Deyn n    Giovanni B. Frisoni  o    Harald Hampel c, d    Roy W. Jones k    
Patrick Kehoe l    Hermine Lenoir q    Lennart Minthon h    Marcel G.M. Olde Rikkert t    
Guido Rodriguez p    Philip Scheltens u    Hilkka Soininen w    Luiza Spiru x    
Jacques Touchon r    Magda Tsolaki y    Bruno Vellas s    Frans R.J. Verhey v    
Bengt Winblad f    Lars-Olof Wahlund g    Gordon Wilcock m    Pieter Jelle Visser u 
 a  Department of Geriatric Psychiatry, Clinic of Psychiatry and Psychotherapy, Central 
Institute of Mental Health, Medical Faculty Mannheim/Heidelberg University,  Mannheim , 
 b  Network Aging Research (NAR), Heidelberg University, Heidelberg,  c  Alzheimer Memorial 
Center, Department of Psychiatry, Ludwig-Maximilian University,  Munich , and  d  Department 
of Psychiatry, Goethe University of Frankfurt,  Frankfurt , Germany;  e  Department of 
Psychology, Stockholm University,  f  KI-Alzheimer Disease Research Center (KI-ADRC), 
Karolinska Institutet, and  g  Section for Clinical Geriatrics, NVS Department, Karolinska 
Institutet, Karolinska University Hospital,  Stockholm , and  h  Clinical Memory Research Unit, 
Department of Clinical Sciences Malmö, Lund University,  Malmö , Sweden;  i  Fundació ACE, 
 Barcelona , Spain;  j  Kingshill Research Centre,  Swindon ,  k  The Research Institute for the Care 
of Older People (RICE),  Bath , and  l  Dementia Research Group, John James Laboratories 
and  m  Department of Care of Elderly, Frenchay Hospital, University of Bristol,  Bristol , 
UK;  n  Institute Born Bunge, Laboratory of Neurochemistry and Behavior, University of 
Antwerp and Memory Clinic ZNA,  Antwerp , Belgium;  o  LENITEM, IRCCS Fatebenefratelli, 
 Brescia , and  p  Clinical Neurophysiology Service Unit, Department of Endocrinological and 
Metabolic Sciences, University of Genoa,  Genoa , Italy;  q  Department of Geriatrics, Hopital 
Broca,  Paris ,  r  Institute National de la Santé et de la Recherche Medicinale INSERM U 888, 
 Montpellier , and  s  Department of Internal Medicine and Clinical Gerontology, Toulouse 
University Hospital,  Toulouse , France;  t  Department of Geriatrics and Radboud Alzheimer 
Centre, Radboud University Medical Centre,  Nijmegen ,  u  Department of Neurology, 
Alzheimer Centre, VU Medical Centre,  Amsterdam , and  v  Department of Psychiatry and 
Neuropsychology, Alzheimer Centre Limburg, Institute of Brain and Cognition, Maastricht 
University Medical Center (MUMC),  Maastricht , The Netherlands;  w  Department of 
Neurology, University of Eastern Finland and Kuopio University Hospital,  Kuopio , Finland; 
 x  Memory Clinic and Geriatric-Alzheimer Unit Clinical Department, ‘Carol Davila’ University 
of Medicine and Pharmacy,  Bucharest , Romania;  y  Aristotle University of Thessaloniki 
Memory and Dementia Centre, 3rd Department of Neurology, G. Papanicolaore General 
Hospital,  Thessaloniki , Greece  
 Accepted: January 8, 2013 
 Published online: May 3, 2013 
 Marinella Damian, PhD 
 Zentralinstitut für Seelische Gesundheit 
 J5, DE–68159 Mannheim (Germany) 
 E-Mail marinella.damian  @  zi-mannheim.de 
 
www.karger.com/dem
 DOI: 10.1159/000348354 
D
ow
nl
oa
de
d 
by
: 
UB
 d
er
 L
M
U 
M
ün
ch
en
   
   
   
   
   
   
   
   
   
   
   
   
 
12
9.
18
7.
25
4.
47
 - 
10
/2
0/
20
14
 2
:3
6:
49
 P
M
2Dement Geriatr Cogn Disord 2013;36:1–19
 DOI: 10.1159/000348354 
 Damian et al.: Single-Domain Amnestic MCI Identified by Cluster Analysis Predicts AD 
in the European Prospective DESCRIPA Study 
www.karger.com/dem
© 2013 S. Karger AG, Basel
 Key Words 
 Mild cognitive impairment · Alzheimer’s disease · Mild cognitive impairment subtypes · 
Conversion to Alzheimer’s disease 
 Abstract 
 Background/Aims: To identify prodromal Alzheimer’s disease (AD) subjects using a data-
driven approach to determine cognitive profiles in mild cognitive impairment (MCI).  Methods: 
A total of 881 MCI subjects were recruited from 20 memory clinics and followed for up to 5 
years. Outcome measures included cognitive variables, conversion to AD, and biomarkers (e.g. 
CSF, and MRI markers). Two hierarchical cluster analyses (HCA) were performed to identify 
clusters of subjects with distinct cognitive profiles. The first HCA included all subjects with 
complete cognitive data, whereas the second one selected subjects with very mild MCI (MMSE 
 ≥ 28). ANOVAs and ANCOVAs were computed to examine whether the clusters differed with 
regard to conversion to AD, and to AD-specific biomarkers.  Results: The HCAs identified 
4-cluster solutions that best reflected the sample structure. One cluster (aMCIsingle) had a 
significantly higher conversion rate (19%), compared to subjective cognitive impairment (SCI, 
p < 0.0001), and non-amnestic MCI (naMCI, p = 0.012). This cluster was the only one showing 
a significantly different biomarker profile (Aβ 42 , t-tau, APOE ε4, and medial temporal atrophy), 
compared to SCI or naMCI.  Conclusion: In subjects with mild MCI, the single-domain amnes-
tic MCI profile was associated with the highest risk of conversion, even if memory impairment 
did not necessarily cross specific cut-off points. A cognitive profile characterized by isolated 
memory deficits may be sufficient to warrant applying prevention strategies in MCI, whether 
or not memory performance lies below specific z-scores. This is supported by our preliminary 
biomarker analyses. However, further analyses with bigger samples are needed to corroborate 
these findings.  Copyright © 2013 S. Karger AG, Basel 
 Introduction 
 Subjects with mild cognitive impairment (MCI) have an increased risk for Alzheimer’s 
disease (AD)  [1] . Previous studies have shown that specific subtypes of MCI are more likely 
to progress to AD-type dementia. However, there is still disagreement concerning the 
conversion rates of these subtypes, which in turn leads to the question of whether it is justified 
to label one of these subtypes the prodromal stage of AD  [2, 3] .
 Previous approaches to define prodromal AD by specific cognitive subtypes had several 
problems. According to Petersen  [4] , MCI can be differentiated into amnestic (aMCI) versus 
non-amnestic (naMCI) subtypes, which can further be divided into the subtypes ‘single 
domain’ and ‘multiple domains’, depending on which and how many cognitive domains are 
impaired  [1, 4] . However, as neither specific tests nor specific cut-off scores are prescribed to 
define cognitive impairment, Petersen’s criteria are often operationalized in many different 
ways. In a Consensus Conference in Stockholm in 2003, these criteria were therefore revised 
by Winblad et al.  [5] . The Stockholm MCI criteria standardized the definition of objective 
cognitive impairment by setting the cut-off point at –1.5 SD, minimizing the risk for false-
positive diagnoses (in contrast to –1.0 SD). However, this cut-off point remains an arbitrary 
criterion. Defining MCI subtypes using pre-specified cut-offs leads to subtypes that are more 
theoretical entities than empirical groups with homogeneous cognitive profiles. Depending 
on the specific cut-off point, the distribution of the subjects across the subtypes can vary 
considerably  [6, 7] . This is all the more evident when bearing in mind that often subjects fall 
into one subtype because they curtly ‘miss’ the alternative one. Hence, one cannot expect the 
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resulting subtypes to be ‘real’ syndromes with a specific underlying pathology and, in turn, 
liability to progress to dementia, not to mention AD.
 Visser and Verhey  [8] examined 320 non-demented patients of a memory clinic and diag-
nosed MCI according to 5 sets of MCI criteria: ageing-associated cognitive decline  [9] , age-
associated memory impairment  [10] , aMCI  [4] , and mild functional impairment  [11] . After 5 
years, 18% of the patients had progressed to AD, but the conversion rate strongly depended 
on the applied criteria and ranged from 20 (ageing-associated cognitive decline) to 38% 
(aMCI). The authors concluded that none of the present MCI concepts is fully predictive of AD 
conversion. Different biomarkers have been identified as useful in detecting prodromal AD, 
but they are still not universally available in routine clinical practice  [12] . Hence, there is still 
a pressing need for further neuropsychological characterization of individuals with MCI who 
are most likely to convert to AD or other types of dementia  [13] .
 The present study intended to identify a data-driven typology of MCI subtypes using hier-
archical cluster analysis (HCA) and to validate the empirical clusters longitudinally, based on 
their rates of conversion to AD and on the basis of AD-specific biomarkers, in order to identify 
one cluster that could be regarded as the pre-clinical stage of AD. Unlike defining MCI subtypes 
using pre-specified cut-offs, cluster analysis determines the grouping of MCI subjects on the 
basis of the data at hand. We started from the assumption that isolating maximally different 
neuropsychological clusters by HCA would help identify one cluster that, in combination with 
a higher rate of conversion to AD and an AD-specific biomarker profile, could be labelled as 
the prodromal AD profile.
 Materials and Methods 
 Study Design, Setting and Participants 
 The study was part of the DESCRIPA project, a 5-year multi-centre prospective cohort study conducted 
within the network of the European Alzheimer’s Disease Consortium  [14] . A cohort of 881 subjects with 
objective or subjective cognitive impairment (SCI, age  ≥ 55) were assessed in 20 European memory clinics 
between March 2003 and March 2007. Subjects with subjective, but no objective cognitive impairment were 
included as MCI (not as healthy control subjects), as they have a higher risk of cognitive decline compared to 
subjects without subjective (and objective) impairment  [15, 16] . Subjects with dementia or any somatic, 
metabolic, psychiatric or neurological disorder that may cause cognitive impairment were excluded. No 
healthy controls were included in the study. The study protocol was approved by the local Medical Ethics 
Committee of each centre. All participants and/or their authorized representatives gave their informed 
consent. For the following analyses, we selected only subjects with complete neuropsychological tests at 
baseline (see below) and at least 1 follow-up (n = 485).
 Measurements 
 Clinical Assessment 
 All subjects underwent a standard battery of examinations, including clinical history, medical/neuro-
logical examinations, laboratory tests, MRI, neuropsychological examinations and clinical rating scales (CDR, 
neuropsychiatric scales, depression scales and ADL scales). Diagnoses were made on the basis of a clinical 
consensus. Both the clinical phenotype (syndrome) and the presumed aetiology were recorded. All subjects 
were invited for annual follow-up assessments for up to 5 years. Dementia was diagnosed according to 
DSM-IV  [17] and AD according to NINCDS-ADRDA criteria  [18] by the diagnostic team at each centre. Outcome 
measures included cognitive variables and progression to AD. Sixteen (80%) of the involved clinics also 
obtained biological data (CSF Aβ 42 , t-tau, p-tau, APOE ε4 genotype, medial temporal lobe atrophy, MTA, and/
or white matter lesions, WML). Data were collected by investigators who were blinded to the results of the 
CSF and blood analyses, as well as to the imaging results. The study methods are described in detail in Visser 
et al.  [14, 19] .
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 Neuropsychological Examination 
 Because the participation of the centres in the DESCRIPA study was intended not to interfere with their 
routine practice, the neuropsychological tests used in this study varied among centres. However, all centres 
assessed the following cognitive domains: memory, language, executive function, attention and visuo-
construction. For each cognitive domain, a primary test was selected at each centre that was the same as, or 
similar, to the tests that were used at the other centres  [14] . The primary tests to assess memory were the 
learning and delayed recall measure of the Rey auditory verbal learning test [ 20 , 6 centres], and the word list 
of the Consortium to Establish a Registry for AD (CERAD) test battery [ 21 , 3 centres]. The primary test to 
assess language was the 1-min verbal fluency test for animals [ 22 , all centres]. The primary test to assess 
speed/attention and executive function was the trail-making test (TMT), parts A and B [ 23 , all centres]. The 
primary tests to assess visuo-construction were the copy subtest of the Rey-Osterrieth complex figure [ 24 , 7 
centres], or the copy of the CERAD figures [ 21 , 2 centres]. If patients had missing data in these primary tests, 
alternative tests were used, which were selected beforehand for each primary test  [14, 19] . All centres 
administered the MMSE  [25] . Raw test scores were transformed to standardized scores wherein the age, 
education and gender of the subjects were taken into consideration. The standardization of the test scores 
was performed using normative data routinely used at each centre. In order to be able to merge the data from 
the different centres, further analyses were performed using z-scores. The relevant methods have been 
detailed elsewhere  [14, 26–29] . For the analyses reported in this paper, the 6 ‘key’ cognitive scores were 
selected, as a relatively big portion of the sample (485 of the 881 subjects) had data in these variables. These 
variables were either single measures of a cognitive domain (e.g. the variable ‘tmt-a’ assessing speed and 
attention on the basis of the TMT-A score alone), or were composite variables containing information from 
tests selected as primary, or alternative tests (e.g. ‘learning’, assessing episodic memory on the basis of 
CERAD, ADAS-cog and word lists of other tests).
 Cerebrospinal Fluid 
 CSF was collected to measure Aβ 42 , t-tau and p-tau with single-parameter ELISA kits. The operators 
analysing the CSF data were blinded to all clinical information. In order to provide reference data for the 
prevalence of a CSF AD profile, 93 healthy controls were selected from another study  [19] . All CSF values 
were expressed as z-scores and corrected for age and gender if appropriate, based on the reference popu-
lation of the healthy control subjects  [14] . The z-scores of Aβ 42 , t-tau and p-tau were inverted such that for 
all measures a more negative z-score indicated a more severe reduction (as was expected for Aβ 42 ) and a 
more positive z-score indicated more elevated concentrations (as was expected for t- and p-tau). Of the 487 
subjects included in this investigation, CSF data were available for 182 subjects from 8 study sites.
 Genetics 
 The APOE ε4 genotype was determined by PCR of genomic DNA, extracted from EDTA anti-coagulated 
blood using the PCR technique  [27] . Data for APOE ε4 were available for 546 subjects from 16 study sites.
 Imaging 
 In some of the centres, subjects underwent a neuroimaging examination, i.e. either CT or MRI, according 
to the routine protocol of the specific centre. Although the scanners and protocols at different sites varied, 
the imaging data were collected and analysed centrally  [27] . For the analyses presented here, 2 imaging vari-
ables were selected: MTA and WML. Both were rated with qualitative rating scales  [24, 25] , using a 5-point 
visual rating scale to assess MTA, and the Age-Related White Matter Changes Scale to assess WML. MTA and 
WML data were available from 10 sites for 370 and 372 subjects, respectively. Subjects with and without data 
for the neuropsychological or biomarker variables did not differ from each other with regard to age, gender 
and education. As the most important conclusions were those drawn from the analyses pertaining to the 
clusters, the only differences tested were those within each cluster.
 Whereas the cluster analyses included 485 subjects with complete data sets in the cognitive variables 
used to build the clusters, only 114, 331 and 246 of the original 881 subjects had data in the CSF, APOE ε4 
and imaging variables, respectively. The analyses reported here included different portions of the complete 
sample, as the sample size would have been reduced to only 71 subjects if only subjects with complete data 
sets in all of the above-mentioned variables had been selected.
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 Statistical Procedures 
 Hierarchical Cluster Analysis 
 HCA was performed to investigate whether the heterogeneous MCI cohort could be differentiated into 
more homogeneous subgroups. To sort the subjects into different clusters, the 6 neuropsychological vari-
ables were entered into the analysis in order to build groups of subjects with possibly homogeneous but 
distinct cognitive profiles. The hierarchical method was chosen because – unlike partitioning methods – it 
does not start from a specific predefined grouping of the elements, but determines the grouping on the basis 
of the data at hand. The clustering of cognitively similar subjects into one group was reached using an agglom-
erative algorithm, where the starting point was the finest partitioning of the elements: at the beginning of the 
clustering procedure each subject constituted its own cluster and subsequently the algorithm put those 
subjects and clusters together to which had the most similar cognitive profile, i.e. which minimized the 
distance or the heterogeneity measure.
 Due to the metric level of the z-transformed neuropsychological scores, the distance measure ‘squared 
euclidean distance’ was chosen, as several linkage algorithms are based on this measure. The Ward method 
was used because other grouping methods have several drawbacks or are very difficult to understand. A 
simulation study by Bergs  [30] showed that, compared to the other algorithms, Ward’s method offers good 
partitions, puts the elements in the ‘correct’ groups and signals the correct number of clusters. The Ward 
algorithm summarizes those elements or clusters which augment the heterogeneity measure (here the 
variance criterion) in a minimal degree, so that Ward’s method is also suitable to build maximally homoge-
neous groups. To help determine the optimal number of clusters, the horizontal hierarchical tree plot was 
used to visualize the course of the used heterogeneity measure during the agglomeration process.
 Two HCA were performed: the first HCA included all 485 subjects with complete cognitive data sets; the 
second HCA was run selecting subjects with baseline MMSE  ≥ 28, i.e. with very mild MCI. We chose MMSE 
 ≥ 28 because in subjects with ‘normal’ educational level (in general at least 8 years), and age  ≥ 65, the corre-
sponding z-scores are still in the normal range  [31] . By this selection we could also rule out a possible 
confounding effect of the overall severity of cognitive impairment on cluster building.
 Logistic Regression Analysis 
 To investigate whether sub-classifying MCI subjects enhances the prediction of AD compared to the 
plain use of cognitive test scores, logistic regression analyses (LRA) were computed, using the variable 
‘conversion to AD’ as the binary dependent variable (converted vs. not converted at follow-up) and the 
cluster and cognitive variables as predictor (independent) variables. Different sets of predictors were 
included as independent variables in order to compare their suitability to predict conversion to AD.
 Three sets of predictors were chosen. The first set contained the 6 aforementioned cognitive variables 
only. The second set included these cognitive variables plus the cluster variable cluster_485. This variable 
resulted from the cluster analysis that included all 485 subjects and contains information about the cluster 
membership of these subjects (e.g. if subject 1 has a ‘2’ in this variable, this means that this subject was clas-
sified into cluster 2, whose label will be described in the results section). The third set of predictors included 
the cognitive variables, the cluster variable cluster_485, and the cluster variable cluster_313. The last-
mentioned variable resulted from the cluster analysis that included only the 313 subjects with very mild MCI, 
i.e. MMSE  ≥ 28. By including this variable as a predictor, the LRA automatically excluded all subjects with 
missing data in this variable. Hence, the results of the analyses run with the third set of predictors apply only 
to the 313 subjects with MMSE  ≥ 28.
 For each of the 3 sets of predictors, two stepwise (‘stepforward’) LRA were computed. In the first ones, 
all predictors were forced into the model in order to determine: (1) the predictive validity of the model 
including all available cognitive information and (2) the order from the best to the least predicting variable. 
To allow all available variables into the model, the inclusion p values were set at 1. In the second analyses, 
the inclusion p values were set at 0.05 so that each variable was expected to increment the prediction by a 
minimum degree in order to be included in the model. These second analyses were run in order to determine 
at which point the algorithm stops including further variables because they do not enhance the predictive 
accuracy, demonstrating which predictors are necessary and sufficient to predict AD. The second analyses 
are denoted with an inverted comma (e.g. model 1’, model 2’, etc.). In order to compare the predictive value 
of the different models, sensitivity, specificity, and positive and negative predictive values were computed. 
Because these predictive values are affected by the prevalence of the disease at hand, the (positive and 
negative) likelihood ratios were also reported. 
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 To validate the MCI clusters identified by the HCAs, ANOVAs and ANCOVAs were computed in order to 
examine whether the clusters differed from each other in their biomarker profiles. The analyses were 
computed using the biomarkers as dependent variables, and the variable ‘MCI clusters’ as the independent 
variable. Because the biomarkers MTA and WML were age dependent, ANCOVAs were computed including 
age as a covariate.
 To examine demographic, clinical and neuropsychological differences between the clusters, genders or 
other groups, additional analyses were conducted: To test for differences between two independent groups, 
we performed Student’s t tests (for continuous variables). In cases where the variances differed between the 
compared groups, the corrected t and d.f. values are reported. Paired-sample t tests were conducted to 
compare the means of 2 variables in one sample. ANOVAs were performed to test for differences between 
more than two groups. In case of significant group differences, the ANOVAs were followed by Games-Howell 
post hoc analyses, as this type of post hoc test takes into account small and/or unequal sample sizes. When 
post hoc tests indicated significant differences between 2 clusters, or 2 cluster pairs only, the reports were 
limited to the (significant) p values. Differences between the distributions of categorical, non-dichotomous 
variables were tested with Pearson’s χ 2 tests. For dichotomous variables, Fisher’s exact tests were computed 
(here, only p values are reported). To test correlations between nominal variables, the phi coefficient and 
odds ratio (OR) were computed. For ordinal variables, or when dichotomous or ordinal variables were corre-
lated with metric variables, Kendall’s tau-b was used. When multiple hypotheses were tested on a set of data, 
the Bonferroni correction was used to avoid cumulating α-errors: when n hypotheses were tested, each indi-
vidual hypothesis was tested at a statistical significance level of 0.05/n or 0.01/n. All tests were two-sided. 
All analyses were performed using the Statistical Package for the Social Sciences (SPSS 19 and IBM SPSS 20).
 Results 
 Descriptives 
 As only subjects with complete neuropsychological tests at baseline and at least 1 follow-
up (n = 485) were included in the analyses, 396 subjects had to be excluded. The baseline 
characteristics of the included (n = 485) and excluded (n = 396) subjects are shown in  table 1 .
 The included subjects were comparable to the excluded subjects in terms of gender (p = 
0.631) and rate of conversion to AD (p = 0.149). However, they differed significantly in terms 
of age [t(878) = 4.125, p < 0.0001], baseline MMSE [t(703) = –5.589, p < 0.0001], and education 
[t(879) = 2.509, p = 0.012]. Both age and education were higher in the excluded subjects 
(age = 71.5 years, education = 10.7 years) compared with the included subjects (age = 69.3 
years, education = 10.0 years), whereas baseline MMSE was lower in the former (27.0) than 
in the latter (27.8). Hence, the included subjects were less cognitively impaired (MMSE) and 
younger, but less educated than the excluded subjects.
 Whereas the mean time to AD and the rate of conversion to AD did not differ significantly 
between the two groups [t(157) = –0.208, p = 0.835 and p = 0.149, respectively], mean follow-
up time differed significantly between the included and the excluded subjects [t(370) = 8.359, 
p < 0.0001]. 
 Demographic Variables and Conversion to AD 
 Of the 485 subjects considered in the first HCA, 91 (18.8%) had developed AD at one of the 
follow-up visits. The risk of conversion to AD increased with age [r(485) = 0.203, p < 0.0001] 
but was not associated with gender [phi(485) = 0.058, p = 0.205; OR(485) = 1.353, 95% CI = 
0.847–2.163] or education [r(485) = –0.022, p = 0.563].  Figure 1 shows the cognitive profiles 
of the ‘converters’ and the ‘non-converters’. The x-axis depicts the cognitive variables (sepa-
rately for converters and non-converters) and the y-axis shows the mean values of their z-scores.
 At baseline, converters (mean MMSE = 26.4, SD = 2.39) and non-converters (mean
MMSE = 28.1, SD = 1.56) differed from each other not only in the magnitude of the cognitive 
deficits [t(107) = 6.738, p < 0.0001] but also in the pattern of relative strengths and weak-
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Table 1.  Baseline characteristics and status at follow-up
Included subjects (n = 485)  Excluded subjects (n = 396)
Immediate recall z-scores –0.76 1.20 4851 –1.09 1.18 3431
Delayed recall –0.85 1.32 4851 –1.34 1.29 2981
Verbal fluency –0.69 0.95 4851 –1.04 1.05 3511
Constructional praxis 0.05 1.16 4851 0.12 1.14 2771
TMT-A –0.74 1.61 4851 –0.61 1.76 2711
TMT-B –0.92 1.91 4851 –1.03 2.08 2571
MMSE 27.8 1.87 4821 27.0 2.48 3871
Age, years 69.35 7.60 4851 71.5 7.94 3951
Female, n, % 275 56.7 4851 231 58.3 3951
Education, years 10.04 4.17 4851 10.7 4.27 3961
Status at follow-up, n % not demented 394 81.2 223 85.1
AD 91 18.8 4851 59 14.9 3961
Follow-up time, years 2.79 0.81 3941 2.10 1.06 2231
Time to AD, years 1.80 0.94 941 1.83 1.02 651
 Data are expressed as mean and SD unless otherwise specified. For the cognitive variables, z-scores are 
listed, indicating the number of SDs from the average of a healthy control population. 1 Number of subjects 
without missing data in the respective variable.
0.5
0
–0.5
–1.0
–1.5
–2.0
–2.5
–3.0
–3.5
–4.0
Non-converters Converters
z-
sc
or
es
Immediate recall (verbal)
Delayed recall (verbal)
Verbal fluency
Constructional praxis
TMT-A
TMT-B
 Fig. 1. Cognitive profiles of ‘converters’ vs. ‘non-converters’. The z-scores on the y-axis indicate the cognitive 
performance of subjects who remained non-demented vs. those who converted to AD at follow-up. Usually, 
z-scores  ≤ –1.5 or  ≤ –1.0 are used to define impaired test performance. 
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nesses. Both groups performed relatively well in constructional praxis. However, only 
converters were significantly more impaired in delayed versus immediate recall [t(90) = 
4.920, p < 0.0001] and in TMT-B versus TMT-A [t(90) = 2.996, p < 0.004], a pattern of 
impairment typical for demented subjects. 
 Differentiating MCI Clusters 
 The horizontal hierarchical tree plot showed that the value of the heterogeneity measure 
escalated after building 4 clusters. Thus, a 4-cluster solution was regarded as the best choice.
 The HCA sorted the 485 subjects into the following 4 clusters: 224 (46.2%) were clas-
sified into cluster 1, 62 (12.8%) into cluster 2, 32 (6.6%) into cluster 3 and 167 (34.4%) into 
cluster 4.  Table 2 lists the baseline scores of the clusters on the 6 cognitive variables, the mean 
MMSE scores, demographics, cluster-specific rates of conversion to AD, mean time to 
conversion, and mean follow-up duration in the 4 clusters.
 Figure 2 specifies the cognitive profiles of the 4 clusters.
 Based on the neuropsychological variables entered into the HCA, the 4 clusters can be 
characterized as follows: 
 • Cluster 1 (n = 224) had subjective cognitive impairments with very mild (if any) objective 
deficits, so that it can be best labelled with ‘SCI’.  
 • Cluster 2 (n = 62) had severe deficits in psychomotor speed, moderate deficits in exec-
utive functioning and mild memory deficits, so that it can be best labelled with ‘inat-
tentive, dysexecutive aMCI’ (aMCIatex).  
 • Cluster 3 (n = 32) had prominent deficits in executive functioning, mild-to-moderate 
memory deficits and mild deficits in verbal fluency. This group was the most impaired 
group and can be best described with ‘dysexecutive aMCI’ (aMCIexec). 
 • Cluster 4 (n = 167) showed deficits in immediate verbal recall that were comparable to 
those in cluster 3, but with more pronounced impairment in delayed memory, without 
executive or attentional deficits. This cluster can be referred to as ‘aMCI, single domain’ 
(aMCIsingle). 
Table 2.  Baseline cognitive scores and status at follow up: HCA sample and clusters (n = 485)
SCI (n = 224) aMCIatex (n = 62) aMCIexec (n = 32)  aMCIsingle (n = 167)
Immediate recall z-scores 0.02 0.93  – 0.92 1.03 –1.69 1.12  – 1.58 0.86
Delayed recall 0.12 0.90  – 0.86 1.02 –1.45 1.11  – 2.02 0.81
Verbal fluency –0.19 0.91  – 0.96 0.84 –1.24 0.78  – 1.14 0.75
Constructional praxis 0.16 1.11  – 0.44 1.32 –0.17 1.29 0.13 1.10
TMT-A –0.03 0.97  – 3.99 0.90 –0.68 0.99  – 0.49 1.06
TMT-B –0.09 1.30  – 3.12 1.74 –4.77 0.46  – 0.47 1.17
MMSE 28.5 1.43 27.02 2.08 26.69 2.16 27.3 1.90
Age, years 67.98 7.45 70.418 5.64 71.26 7.63 70.416 8.14
Female, n, % 121 54.0 45 72.6 23 71.9 86 51.5
Education, years 10.79 4.20 6.98 3.29 8.69 4.04 10.43 3.90
Status at follow-up, n, % not demented 216 96.4 47 75.8 17 53.1 114 68.3
AD 8 3.6 15 24.2 15 46.9 53 31.7
Follow-up time, years 2.89 0.82 2.49 0.58 2.76 0.56 2.72 0.87
Time to AD, years 1.43 0.53 1.80 0.56 1.60 0.74 1.63 0.75
 Data are expressed as mean and SD unless otherwise specified. For the cognitive variables, z-scores are listed, indicating the 
number of SDs from the average of a healthy control population.
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 After Bonferroni correction (a = 0.05/6 = 0.008), the clusters differed in terms of age [F(3, 
478) = 4.759, p = 0.003], baseline MMSE [F(3, 478) = 24.914, p < 0.0001] and education [F(3, 
478) = 16.657, p < 0.0001]. Whereas age differed significantly between SCI on the one hand 
and aMCIatex and aMCIsingle on the other (p = 0.030 and p = 0.013, respectively), baseline 
MMSE differed between SCI and each of the 3 other clusters (p < 0.0001). As to differences in 
education, there was a tendency of the least impaired clusters (SCI and aMCIsingle) to have 
more years of education than the more impaired clusters (aMCIatex and aMCIexec). However, 
differences in education were significant only between aMCIatex and the SCI and aMCIsingle 
clusters (both p < 0.0001). As for age at first visit, the cluster with the lowest mean age (67.9 
years) was the least impaired SCI cluster. However, the order from the ‘youngest’ to the 
‘oldest’ cluster (SCI, aMCIatex, aMCIsingle and aMCIexec) was neither consistent with the 
overall degree of cognitive impairment (MMSE) or the number of impaired cognitive func-
tions, nor did these differences reach significance level. As for gender distribution, the signif-
icant inter-cluster difference [χ 2 (3) = 11.868, p = 0.008] was due to the differences of SCI 
versus aMCIatex (54.0 vs. 72.6% females, p = 0.009) and aMCIsingle versus aMCIatex (51.5 
vs. 72.6% females, p = 0.004). After Bonferroni correction (p = 0.05/6 = 0.0083) only the 
latter difference remained significant. Severity of depressive symptoms was highest in 
aMCIatex and differed significantly from severity in SCI [t(90) = –2.327, p = 0.022] and in 
aMCIsingle [t(95) = 2.235, p = 0.028]. However, after Bonferroni correction (p′ = 0.0083), 
neither of these differences remained significant. 
 In which neuropsychological variables the clusters differed significantly from one anoth-
er is reported in  table 3 .
1
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SCI aMCIatex aMCIexec aMCIsingle
 Fig. 2. Cognitive profiles of the 4 clusters identified in the complete sample (n = 485). The z-scores on the 
y-axis indicate the cognitive performance of the SCI, aMCIatex, aMCIexec and aMCIsingle clusters. Usually, 
z-scores  ≤ –1.5 or  ≤ –1.0 are used to define impaired test performance. 
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 Conversion to AD, Mean Time to Conversion, and Mean Follow-Up Duration 
 The cluster-specific rates of conversion to AD, mean time to conversion and mean follow-
up duration in the 4 clusters are reported in  table 2 . The highest conversion rate was found 
in the aMCIexec cluster (46.9%), which differed significantly from that of the aMCIatex cluster 
(24.2%, p = 0.036). However, after Bonferroni correction (0.05/3 = 0.016) this difference was 
no longer significant. Because significantly lower conversion rates were self-evident in 
subjects with just SCI, only the rates of the clusters with objective cognitive impairment were 
compared with one another. The clusters did not differ with regard to the mean time to AD 
either [F(3, 84) = 0.489, p = 0.691], whereas the average follow-up time was significantly 
longer in the SCI than in the aMCIatex cluster (p = 0.001). Whereas time to AD was computed 
selecting subjects who converted to AD, follow-up time was examined only in subjects who 
did not convert, in order to avoid comparing it between groups with different conversion 
rates (and hence different follow-up times, as converters dropped out of the study earlier).
 Differentiating MCI Clusters of Subjects with MMSE  ≥ 28 
 A second HCA was conducted to test if the stability of the clusters could also be demon-
strated in subjects with very mild MCI. In order to test if a cognitive profile predicting AD can 
be identified at a very early stage of MCI, only subjects with a baseline MMSE  ≥ 28 (n = 313) 
were selected for the second HCA. This HCA generated, again, 4 clusters whose cognitive 
profiles are shown in  figure 3 .
 Based on the cognitive performance of the subjects, the 4 new clusters are characterized 
as follows:
 • Cluster 1 (n = 86, mean MMSE = 29.1, SD = 0.73; mean age = 66.3, SD = 7.74) had no 
objective cognitive deficits, hence this cluster was labelled ‘SCI’ (SCI28+). 
 • Cluster 2 (n = 116, mean MMSE = 28.8, SD = 0.70; mean age = 68.5, SD = 7.94) had moderate 
deficits in immediate verbal recall, even more pronounced impairment in delayed recall, 
and minimal impairment in verbal fluency. This cluster was labelled ‘aMCI, single domain’ 
(aMCIsingle28+). 
 • Cluster 3 (n = 51, mean MMSE = 28.7, SD = 0.83; mean age = 71.0, SD = 6.62) had prominent 
deficits in executive functioning, almost similar impairment in attention and psychomotor 
speed, and minimal impairment in verbal fluency and memory. This group was labelled 
‘attentional and executive impairment with secondary memory deficits’ (atexMCI28+).  
 • Cluster 4 (n = 60, mean MMSE = 29.0, SD = 0.75; mean age = 68.6, SD = 7.09) showed no 
memory deficits but mild impairment in constructional praxis, executive functioning and 
verbal fluency. This cluster was labelled ‘naMCI’ (naMCI28+). 
Table 3.  Complete sample clusters: differences in the cognitive variables (Games-Howell post hoc tests)
MCI clusters 
(n = 485)
Cognitive variables
immediate 
recall
delayed recall verbal fluency construc-
tional praxis
TMT-A TMT-B
I J I–J p I–J p  I–J p I–J p  I–J p  I–J p
aMCIatex aMCIexec 0.768 0.011 0.589 0.069  0.273 0.404 –0.276 0.767 –3.317 <0.0001 1.656 <0.0001
 aMCIsingle 0.661 <0.0001 1.157 <0.0001 0.175 0.478 –0.570 0.016 –3.505 <0.0001 –2.642 <0.0001
aMCIexec aMCIsingle –0.106 0.957 0.568 0.043  –0.098 0.912 –0.295 0.627 –0.188 0.767  –4.298 <0.0001
 I–J = Mean difference; Bonferroni-corrected significance level: 0.05/6 = 0.008.
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 After Bonferroni correction (a = 0.05/6 = 0.008), the clusters did not differ with regard 
to baseline MMSE except for the difference between SCI28+ and aMCIsingle28+ (p = 0.003). 
The clusters SCI28+ and atexMCI28+ differed significantly with regard to age (p = 0.001) and 
education (p < 0.0001). Education differed also between aMCIsingle28+ and atexMCI28+ 
(p < 0.0001), with aMCIsingle28+ being more educated than atexMCI28+. Severity of depres-
sive symptoms differed between the clusters too [F(3, 250) = 2.707, p = 0.046]. Games-
Howell post hoc comparisons indicated that the inter-cluster difference in depressive symp-
toms was only attributable to the difference SCI28+ versus atexMCI28+ (p = 0.045). In 
contrast to aMCIsingle28+, where delayed recall was slightly more impaired than immedi-
ate recall (t = 1.70; d.f. = 115; p = 0.092), an opposite tendency was present in atexMCI28+ 
(t = –1.568; d.f. = 50; p = 0.123), although both results were not significant. In summary, 
atexMCI28+ was the cluster with the lowest education level and the highest severity of 
depressive symptoms. There were no differences in gender distribution [χ 2 (3) = 1.438, p = 
0.697].
 In which neuropsychological variables the ‘very mild MCI’ clusters differed significantly 
from one another is reported in  table 4 . 
 Conversion to AD, Mean Time to Conversion, and Mean Follow-Up Duration in the MMSE 
 ≥ 28 Clusters 
 In the subset of subjects with milder cognitive impairment (MMSE  ≥ 28), the highest 
conversion rate was found in the aMCIsingle cluster (19%), which differed significantly 
2.0
1.0
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or
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SCI28+ naMCI28+ atexMCI28+ aMCIsingle28+
Immediate recall (verbal)
Delayed recall (verbal)
Verbal fluency
Constructional praxis
TMT-A
TMT-B
 Fig. 3. Cognitive profiles of the 4 clusters identified in the very mild MCI (MMSE  ≥ 28) sample (n = 313). 
The z-scores on the y-axis indicate the cognitive performance of the SCI28+, naMCI28+, atexMCI28+ and 
aMCIsingle28+ clusters. Usually, z-scores  ≤ –1.5 or  ≤ –1.0 are used to define impaired test performance. 
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from the conversion rate of naMCI (5%, p = 0.012, Bonferroni-corrected significance level: 
0.05/3 = 0.016). Time to AD did not differ between the clusters [F(3, 26) = 0.446, p = 0.722], 
whereas the average follow-up time was significantly longer in SCI28+ than in atexMCI28+ 
(p = 0.004).
 Predicting Conversion to AD: Does Sub-Classifying MCI Subjects Improve the Diagnostic 
Accuracy of the Cognitive Scores? 
 In order to determine whether knowledge of the subtype or cluster of an MCI subject has 
an additional benefit to the prediction of conversion to AD compared to the plain use of the 
subjects’ cognitive scores, 6 LRA were performed, using different combinations of potentially 
predicting variables. The 6 resulting models are presented in  table 5 .
 According to the LRA that included the cognitive variables only (models 1 and 1’), 
conversion to AD at follow-up was correctly predicted in 84.5% of the cases. Specificity 
amounted to 96.4% and sensitivity to 33.0% (model 1). In model 1’, where the LRA algorithm 
stopped including further variables if they did not enhance the predictive accuracy, the vari-
ables of delayed recall, TMT-B and verbal fluency were identified as the best predictors. The 
variables of verbal immediate recall, constructional praxis and TMT-A did not contribute to 
the prediction of conversion to AD (p = 0.275, p = 0.828 and p = 0.849, respectively). While 
the predictive accuracy of the 6 cognitive variables (model 1) remained virtually unaffected 
by the exclusion of the redundant cognitive variables (model 1’, see  table 6 ) in both models, 
high specificity values are derogated by low sensitivity values.
 To examine whether the clustering of the MCI sample improves prediction of AD, the 
models 1 and 1’ were supplemented by two further models (models 2 and 2’): in model 2, the 
6 aforementioned cognitive variables plus the cluster_485 variable were included. In model 
3, these model 2 predictors were supplemented by the cluster_313 variable.
 In model 2, the order of the included variables shows that the cluster_485 variable was 
slightly more predictive than the redundant variables identified in model 2’. However, the 
contribution of the cluster_485 variable was not significant (p = 0.292), so that the predictive 
accuracy of this set of predictors does not significantly improve, compared to models 1 and 1’.
 In contrast, model 3, which also included the cluster_313 variable, showed another 
picture: here, the LRA algorithm selected the cluster_485 variable as the best predictor, 
followed by the variables of delayed recall, TMT-B and immediate recall. In model 3’ the algo-
rithm excluded all variables but cluster_485 (best predictor) and delayed recall (second-best 
predictor). However, in model 3’ sensitivity is significantly reduced compared to model 3. On 
the basis of these 2 ‘best’ variables, AD was predicted for only 1 subject who, at least in the 4 
years of follow-up, did not progress to AD. 
Table 4.  MMSE 28+ clusters: differences in the cognitive variables (Games-Howell post hoc tests)
MCI Clusters 28+
(n = 313)
Cognitive variables
immediate 
recall
delayed recall verbal
fluency
constructional
praxis
TMT-A  TMT-B
I J I–J p I–J p I–J p I–J p I–J p I–J p
aMCIsingle28+ atexMCI28+ –0.819 <0.0001 –1.184 <0.0001 –0.130 0.753 0.514 0.058 2.375 <0.0001 3.077 <0.0001
naMCI28+ –1.46 <0.0001 –1.668 <0.0001 –0.476 0.003 0.854 <0.0001 0.159 0.702 0.358 0.147
atexMCI28+ naMCI28+ –0.638 0.003 –0.484 0.016 –0.346 0.118 0.341 0.445 –2.217 <0.0001 –2.719 <0.0001
 I–J = mean difference; Bonferroni-corrected significance level: 0.05/6 = 0.008.
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Table 5.  LRA to predict conversion to AD
Predictors β SE (β) Wald d.f. p Expected (β), OR
Model 1 delayed recall –1.085 0.182 35.648 1 <0.0001 0.338
TMT-B –0.224 0.082 8.932 1 0.003 0.784
verbal fluency –0.465 0.181 6.614 1 0.010 0.628
immediate recall 0.192 0.176 1.191 1 0.275 1.211
constructional praxis –0.026 0.120 0.047 1 0.828 0.974
TMT-A –0.018 0.094 0.036 1 0.849 0.982
constant –3.458 0.327 112.141 1 <0.0001 0.031
Model 1’ delayed recall –0.957 0.138 48.39 1 <0.0001 0.384
TMT-B –0.236 0.069 11.65 1 0.001 0.790
verbal fluency –0.461 0.180 6.58 1 0.010 0.631
constant –3.471 0.320 118.024 1 <0.0001 0.031
Model 2 delayed recall –0.990 0.201 24.212 1 <0.0001 0.372
TMT-B –0.258 0.082 9.885 1 0.002 0.773
verbal fluency –0.415 0.186 4.968 1 0.026 0.661
immediate recall 0.218 0.178 1.509 1 0.219 1.244
cluster_485 0.173 0.164 1.112 1 0.292 1.188
TMT-A –0.036 0.096 0.142 1 0.707 0.965
constructional praxis –0.032 0.120 0.072 1 0.788 0.968
constant –3.782 0.468 65.411 1 <0.0001 0.023
Model 2’ delayed recall –0.957 0.138 48.390 1 <0.0001 0.384
TMT-B –0.236 0.069 11.650 1 0.001 0.790
verbal fluency –0.461 0.180 6.578 1 0.010 0.631
constant –3.471 0.320 118.024 1 <0.0001 0.031
Model 3 cluster_485 0.787 0.286 7.600 1 0.006 2.198
delayed recall –0.823 0.287 8.242 1 0.004 0.439
TMT-B –0.225 0.137 2.700 1 0.100 0.798
immediate recall 0.592 0.287 4.261 1 0.039 1.807
cluster_313 0.363 0.391 0.861 1 0.353 1.438
TMT-A 0.096 0.173 0.311 1 0.577 1.101
constructional praxis –0.064 0.195 0.106 0.745 0.938
verbal fluency 0.026 0.291 0.008 1 0.928 1.027
constant –5.797 1.451 15.956 1 <0.0001 0.003
Model 3’ cluster_485 0.554 0.230 5.798 1 0.016 1.740
delayed recall –0.512 0.241 4.502 1 0.034 0.599
constant –4.292 0.627 46.933 1 <0.0001 0.014
Overall model evaluation –2LL R2 χ2 d.f. p
Model 1
n = 485
348.499 0.353 119.784 6 <0.0001
Model 1’ 349.812 0.350 118.471 3 <0.0001
Model 2
n = 485
347.371 0.356 120.913 7 <0.0001
Model 2’ 349.812 0.350 118.471 3 <0.0001
Model 3
n = 313
153.028 0.305 49.152 8 <0.0001
Model 3’ 162.124 0.252 40.056 2 <0.0001
R2 = Nagelkerke’s R2.
 PPV and NPV = Positive and negative predictive value, respectively; LR+ and LR– = positive and negative likelihood ratio, 
respectively.
Model 1: All 6 cognitive variables ‘forced’ into the model by setting P(IN) and P(OUT) = 1.
Model 1’: Only the best predicting cognitive variables ‘allowed’ into the model, P(IN) = 0.05, P(OUT)= 0.10.
Model 2: All 6 cognitive variables plus the cluster_485 variable ‘forced’ into the model.
Model 2’: Only the best predicting variables of model 2 allowed into the model.
Model 3: All 6 cognitive variables plus both cluster variables (cluster_485 and _313) forced into the model.
Model 3’: Only the best predicting variables of model 3 allowed into the model.
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 In summary, in all 3 sets of predictors high specificity values were derogated by very low 
sensitivity values, showing that they are accurate only in identifying non-converters, but not 
subjects who later convert to AD. However, model 3 contains both the cognitive and cluster 
variables that can be regarded as the combination of variables with the highest predictive 
accuracy (91.1%) and the lowest decrement in sensitivity (12.9%) and positive predictive 
value (80%).
 It has to be mentioned that these results (models 3 and 3’) only apply to the 313 subjects 
who were included in the respective LRAs, as all other subjects with missing data in the 
cluster_313 variable (i.e. subjects with MMSE <28) were automatically excluded. Hence, the 
last-mentioned results apply only to subjects with MMSE  ≥ 28, i.e. very mild MCI.
 Inter-Cluster Differences in Biomarkers 
 Table 7 shows the results of the ANOVAs and ANCOVAs computed to test for significant 
inter-cluster differences in the biomarkers.
 ANOVAs and ANCOVAs were computed separately for the two HCA samples. In both 
samples, the aMCIsingle subtype (aMCIsingle28+) was the only one which differed signifi-
cantly from the SCI cluster. However, while in the complete sample aMCIsingle was associated 
with abnormalities in Aβ 42 , t-tau and MTA, in the very mild MCI sample it was associated with 
a significantly ‘abnormal’ MTA only. In the very mild MCI sample, CSF markers did not differ 
from those of the cognitively healthy SCI subjects. Interestingly, APOE ε4 differed significantly 
between aMCIsingle28+ and the naMCI group, but only in the very mild MCI subjects.
 Discussion 
 HCA subdivided an MCI cohort into 4 groups with maximally different cognitive profiles 
which differed in their rates of conversion to AD: (1) SCI, (2) mainly attentional with addi-
tional executive and amnestic impairment (aMCIatex), (3) mainly executive impairment 
(aMCIexec) and (4) mainly amnestic impairment (aMCIsingle). The highest rate of conversion 
Table 6.  Diagnostic accuracy of different LRA models
Diagnostic
accuracy, %
Sensitivity
%
Specificity
%
PPV
%
NPV
%
LR+ LR–
Model 1 84.5 33.0 96.4 68.2 86.2 –0.346 –0.332
Model 1’ 84.5 31.9 96.7 69.0 86.0 –0.333 –0.319
Model 2 84.9 35.2 96.4 69.6 86.6 –0.369 –0.355
Model 2’ 84.5 31.9 96.7 69.0 86.0 –0.333 –0.319
Model 3 91.1 12.9 99.6 80.0 91.2 –0.131 –0.119
Model 3’ 89.8 0 99.6 0 90.1 0 –0.010
 PPV and NPV = Positive and negative predictive value, respectively; LR+ and LR– = positive and negative 
likelihood ratio, respectively.
Model 1: All 6 cognitive variables ‘forced’ into the model by setting P(IN) and P(OUT) = 1.
Model 1’: Only the best predicting cognitive variables ‘allowed’ into the model, P(IN) = 0.05, P(OUT)= 0.10.
Model 2: All 6 cognitive variables plus the cluster_485 variable ‘forced’ into the model.
Model 2’: Only the best predicting variables of model 2 allowed into the model.
Model 3: All 6 cognitive variables plus both cluster variables (cluster_485 and _313) forced into the model.
Model 3’: Only the best predicting variables of model 3 allowed into the model.
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to AD was found in the aMCIexec cluster (46.9%), followed by aMCIsingle (31.7%), aMCIatex 
(24.2%) and SCI (3.6%).
 Because the cluster with the highest rate of conversion (aMCIexec) also had the lowest 
baseline MMSE, an additional HCA was run selecting subjects with baseline MMSE  ≥ 28, i.e. 
very mild MCI, to rule out a possible confounding effect of the overall severity of cognitive 
impairment on cluster building. This second HCA identified the following 4 clusters: (1) SCI 
(SCI28+), (2) mainly amnestic impairment (aMCIsingle28+), (3) mainly executive and atten-
tional deficit plus slight memory impairment (atexMCI28+) and (4) mainly constructional, 
non-amnestic impairment (naMCI28+). Because of the MMSE  ≥ 28 criterion, the corre-
sponding rates of conversion to AD were much lower than those found in the complete sample 
clusters (1.2, 19, 9.8 and 5%, respectively). Nevertheless, 2 of these 28+ clusters (SCI28+ and 
aMCIsingle28+) had similar cognitive profiles to those found in the original HCA, with an 
interesting difference: whereas aMCIexec was the high-risk cluster of the complete sample 
HCA solution, aMCIsingle28+ was the high-risk cluster in the MMSE28+ cluster solution. 
Hence, examining only subjects with very mild MCI, single-domain aMCI was identified as the 
most probable prodromal AD phenotype in spite of its lower degree of deficit multiplicity and 
its similar severity of global cognitive impairment (mean MMSE) compared to atexMCI28+. 
Thus, the number and severity of impaired cognitive domains do not seem to matter as much 
as the degree of memory impairment. In fact, executive functioning was much more impaired 
in the atexMCI28+ than memory in the aMCIsingle28+ cluster. Still, the highest conversion 
rate (19%) was found in the latter, which had the highest memory impairment. Hence, in the 
earliest stages of cognitive impairment, prominent memory impairment is crucial and suffi-
cient to enhance the risk of conversion, so that single-domain aMCI might be labelled the 
earliest cognitive phenotype of AD. In the atexMCI28+ cluster, impaired memory perfor-
mance can partly be explained by the pronounced attentional and executive deficits, which 
are cognitive features more typical for depressive subjects than for degenerative brain 
processes. In fact, atexMCI28+ was the cluster with the most severe depressive symptoms. 
Furthermore, only the aMCIsingle28+ cluster showed a tendency to the dementia-specific 
pattern of more impaired delayed recall and less impaired immediate recall  [32] .
 According to most of the studies on conversion rates of MCI subtypes, single-domain 
aMCI is less likely to convert to AD compared to multiple-domain aMCI, because the memory 
component specific for AD and the multiplicity of cognitive deficits indicating the severity of 
brain destruction interact, which results in a higher risk of progression to dementia  [3, 33–40] . 
This is in line with our results in the total cohort, but was not confirmed in the very mildly 
Table 7.  Inter-cluster differences in biomarkers
Biomarkers Complete sample (n = 485)  MMSE28+ sample (n = 313)
differing clusters p differing  clusters p
Aβ42 SCI vs. aMCIsingle 0.014 n.s. n.s.
t-tau SCI vs. aMCIsingle 0.044 n.s. n.s.
p-tau n.s. n.s. n.s. n.s.
APOE ε4 n.s. n.s. naMCI28+ vs. aMCIsingle28+ 0.039
MTA SCI vs. aMCIsingle <0.0001 SCI vs. aMCIsingle28+ <0.0001
WML n.s. n.s.  n.s. n.s.
 To test for inter-cluster differences in the biomarkers Aβ42, t-tau, p-tau and APOE ε4, ANOVAs were 
computed. ANCOVAs were computed to test for inter-cluster differences in MTA and WML, as these variables 
were not age-corrected and age had to be entered as a covariate.
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impaired cohort. This supports the suggestion of Hughes et al.  [41] that multiple-domain 
aMCI represents a more advanced disease state.
 In the complete sample, the aMCIsingle cluster was associated with an AD-specific 
biomarker profile: decreased Aβ 42 , increased t-tau, and MTA, compared to subjects with only 
SCI. The biomarker differences might have been even more pronounced if healthy controls 
had been included in the study, as Visser et al.  [19] could show in another study. In the MMSE 
 ≥ 28 sample, CSF markers could not differentiate between any of the clusters, probably 
because CSF markers become abnormal very early, even in subjects who will in their lifetime 
never express symptoms of AD dementia, and do not change appreciably as the disease 
progresses  [42] . WML did not differentiate between any of the clusters, whereas APOE ε4 
differed between aMCIsingle and naMCI. However, MTA was the only biomarker which 
consistently and highly significantly differentiated between SCI and aMCIsingle both in the 
complete and in the MMSE  ≥ 28 sample. This is in line with the hypothetical model of dynamic 
AD biomarkers of Jack et al.  [42] , stating that the direct substrate of memory impairment is 
hippocampal atrophy (as measured by MRI) and not, for example, Aβ deposition.
 The results of this study have to be seen in light of some limitations. As the study popu-
lation was recruited from memory clinics, the results may not be generalized to other settings 
or to the general population. As the number of included cognitive tests was limited because 
of the multi-centre and naturalistic nature of the study, the study findings are specific to the 
tests that were selected. In addition, this study was carried out without a healthy control 
group, as the included subjects with no objective cognitive impairment all had subjective 
concerns and, hence, a higher risk of developing cognitive deficits and converting to dementia 
compared to truly healthy controls  [15, 16] . Another problem of this and other studies 
comparing the conversion risk of aMCI versus naMCI subtypes could also have led to biased 
results: identifying clusters with memory impairment as the most susceptible ones to convert 
to AD could reflect a tautological problem. In order to diagnose dementia, i.e. to decide 
whether a subject has converted to dementia or not, memory impairment is, by definition, a 
necessary prerequisite. Hence, subjects with a baseline cognitive profile corresponding to 
naMCI are less probable to be judged as ‘converted’ (to dementia or AD) at follow-up, because 
they have to develop memory deficits in the first place. However, if only amnestic forms of 
MCI are taken into consideration, this problem concerns both multiple- and single-domain 
aMCI. Actually, it affects multiple-domain aMCI in particular, as memory impairment has to 
be accompanied by deficits in at least one additional cognitive domain in order to fulfil 
dementia criteria. Because single- and not multiple-domain aMCI was found to be the most 
susceptible to convert to AD, the aforementioned tautology does not explain this specific 
result. However, tautology problems have to be taken into consideration as a source of bias 
affecting results pertaining to the comparison between amnestic and non-amnestic clusters. 
Another limitation of this study is the lack of a measure of ‘cued recall’ like, for example, the 
Free and Cued Selective Reminding test, which has been found to correlate with CSF biomarkers 
of AD more strongly than CERAD delayed recall measures  [43] and to accurately predict MTA, 
as semantic cuing draws upon hippocampal and entorhinal structures  [44] . Furthermore, the 
study is limited by the fact that the MCI clusters were built on the basis of their cognitive 
profiles only, even if they could be correlated with AD-specific biomarkers afterwards. Finally, 
in all logistic regression models, sensitivity values were low (range = 0–35.2%), while accuracy 
(84.5–91.1%) and specificity (96.4–99.6%) of the various variables and clusters predicting 
incident AD were high. Hence, the cognitive variables used in the analyses were accurate in 
identifying subjects  not at risk of developing AD, but they were not sensitive to detect those 
who  are at risk. This is consistent with the results of Stephan et al.  [45] , who found that ‘no 
MCI-derived threshold accurately identified an at-risk group with a 2-year progression rate 
greater than 20%’. 
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Appendix
Clusters of the complete sample (n = 485)
SCI Subjective cognitive impairment
aMCIatex Inattentive, and dysexecutive amnestic MCI
aMCIexec Dysexecutive amnestic MCI
aMCIsingle Single-domain amnestic MCI
Clusters of the MMSE ≥28 sample (n = 313)
SCI28+ Subjective cognitive impairment (MMSE ≥28)
aMCIsingle28+ Single-domain amnestic MCI (MMSE ≥28)
atexMCI28+ Inattentive, and dysexecutive MCI with mild memory deficits (MMSE ≥28)
naMCI28+ Non-amnestic MCI (MMSE ≥28)
 To our knowledge, this is the first prospective study investigating the conversion rates of 
MCI subtypes defined on an empirical basis using HCA. This method was chosen to find homo-
geneous groups having in common not only performance below specific cut-off points (as it 
is often the case when building MCI subtypes), but ‘real’ underlying cognitive profiles. 
According to analyses where a  theoretical sub-classification of MCI subjects (using 1.5 SD as 
the cut-off) was compared with the  empirical one (using cluster analyses as presented in this 
paper), the theoretically specified subtype with the highest conversion rate to AD was 
multiple-domain aMCI. In clinical routine, where the aforementioned cut-off is used to define 
impairment, this cognitive profile would, at least in neuropsychological terms, already meet 
criteria for dementia and identify subjects at risk too late. In fact, some subjects in this theo-
retical subtype had particularly low baseline MMSE values.
 In summary, our results are consistent with those of other investigators finding that 
amnestic forms of MCI are at higher risk of progressing to dementia or AD compared to non-
amnestic forms of MCI  [35] . Considering only subjects with baseline MMSE values  ≥ 28, i.e. 
subjects with very mild MCI, single-domain aMCI was identified as the most susceptible form 
to progress to AD. This is consistent with our biomarker analyses and with the notion of 
hippocampal damage leading to isolated memory deficits. Furthermore, our results confirm 
that delayed recall measures and MTA are the most useful markers of conversion to AD  [46] , 
and that today imaging data still seem to be better immediate predictors of conversion to AD 
than CSF markers  [47] . According to the model of the AD pathological cascade in the study of 
Jack et al.  [42] , MRI markers are more predictive of conversion to AD than CSF markers, as 
they are the last to become abnormal and the most proximate pathological substrate of 
cognitive symptoms.
 The results of this study are also of clinical relevance. The pattern of cognitive weak-
nesses and strengths of MCI subjects is predictive of AD, whether or not they perform below 
specific cut-off z-scores. Prodromal AD should already be taken into consideration in the 
presence of isolated memory impairment, even if the subject’s performance has not yet 
crossed specific cut-off points. This is supported by our preliminary biomarker analyses. 
However, further analyses are needed to corroborate this finding.
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